discovery of selective RNA-binding proteins
synthetic RNA-oligonucleotides
sustained quality of life
healthier quality of life
non-canonical modifications
natural mRNA
project
plethora of natural chemical modifications
increase of life expectancy
occurrence of neurological diseases
Non-canonical nucleoside incorporation
unavoidable cost
gene expression
multidisciplinary field
biological processes
aforementioned conditions
expression of genes
overall aim
mRNA of human cancer cell lines
chemical synthesis of modified oligoribonucleotides
cost society vast amounts of money
investigations
design of new therapies
treatment
mechanisms responsible
Parkinsonâ€™s
rise
world
structure
major bottleneck
long term lead
better understanding
chemistry
biology meet
Gm
novel technologies
possibility
innovative methods
specific interaction
responsibility of scientists
mass spectrometric techniques
Michaelides
prevention
unique training
ms2i6A
debilitating ones
tuning of translation
difficulty
oligoribonucleotide strands
care of patients
foundation
obesity
years
cellular extracts
academic career